Insider · CIK 0001612357

Gennadios Aristippos

Reports to the SEC for 1 company · SOMERSET, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001612357

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-12-18	Catalent, Inc.D Disposition to Issuer	Group Pres. Pharma & Consumer	DDisposition to Issuer	−114K sh	—	—	0
2024-12-18	Catalent, Inc.A Award	Group Pres. Pharma & Consumer	AAward	+21.6K sh	—	—	21,562
2024-12-18	Catalent, Inc.D Disposition to Issuer	Group Pres. Pharma & Consumer	DDisposition to Issuer	−21.6K sh	—	—	0
2024-08-02	Catalent, Inc.S Sale	Group Pres. Pharma & Consumer	SSale	−1,169 sh	$59.55	−$69.6K	113,724
2024-07-29	Catalent, Inc.S Sale	Group Pres. Pharma & Consumer	SSale	−349 sh	$58.70	−$20.5K	114,893
2024-07-26	Catalent, Inc.A Award	Group Pres. Pharma & Consumer	AAward	+18.7K sh	—	—	115,242
2023-12-08	Catalent, Inc.A Award	Group Pres. Pharma & Consumer	AAward	+1,505 sh	—	—	96,863
2023-12-08	Catalent, Inc.F Tax Payment	Group Pres. Pharma & Consumer	FTax Payment	−367 sh	$37.18	−$13.6K	96,496
2023-08-24	Catalent, Inc.J Other	Group Pres. Pharma & Consumer	JOther	+396 sh	—	—	95,358
2023-08-24	Catalent, Inc.S Sale	Group Pres. Pharma & Consumer	SSale	−396 sh	$44.49	−$17.6K	96,552
2023-08-23	Catalent, Inc.J Other	Group Pres. Pharma & Consumer	JOther	−1,590 sh	—	—	94,962
2023-08-23	Catalent, Inc.A Award	Group Pres. Pharma & Consumer	AAward	+1,590 sh	—	—	96,948
2023-08-01	Catalent, Inc.S Sale	Group Pres. Pharma & Consumer	SSale	−61 sh	$46.58	−$2,841.38	86,708
2023-08-01	Catalent, Inc.S Sale	Group Pres. Pharma & Consumer	SSale	−220 sh	$47.87	−$10.5K	86,488
2023-08-01	Catalent, Inc.A Award	Group Pres. Pharma & Consumer	AAward	+8,870 sh	—	—	95,358
2023-08-01	Catalent, Inc.Options to purchase Common StockA Award	Group Pres. Pharma & Consumer	AAward	+19.8K sh	—	—	19,756
2022-08-25	Catalent, Inc.S Sale	Group Pres. Pharma & Consumer	SSale	−1,645 sh	$103.04	−$170K	86,769
2022-08-24	Catalent, Inc.A Award	Group Pres. Pharma & Consumer	AAward	+6,771 sh	—	—	88,414
2022-07-26	Catalent, Inc.S Sale	Group Pres. Pharma & Consumer	SSale	−403 sh	$106.90	−$43.1K	79,784
2022-07-26	Catalent, Inc.A Award	Group Pres. Pharma & Consumer	AAward	+1,859 sh	—	—	81,643
2022-07-26	Catalent, Inc.Options to purchase Common StockA Award	Group Pres. Pharma & Consumer	AAward	+8,078 sh	—	—	8,078
2022-07-01	Catalent, Inc.A Award	Group Pres. Pharma & Consumer	AAward	+18.7K sh	$107.02	+$2M	80,187
2022-01-03	Catalent, Inc.A Award	Group Pres. Pharma & Consumer	AAward	+4,017 sh	—	—	61,498
2021-08-27	Catalent, Inc.S Sale	Group Pres. Pharma & Consumer	SSale	−171 sh	$130.29	−$22.3K	59,572
2021-08-27	Catalent, Inc.S Sale	Group Pres. Pharma & Consumer	SSale	−2,091 sh	$131.20	−$274K	57,481
2021-08-26	Catalent, Inc.A Award	Group Pres. Pharma & Consumer	AAward	+8,008 sh	—	—	59,743
2021-07-26	Catalent, Inc.S Sale	Group Pres. Pharma & Consumer	SSale	−465 sh	$113.05	−$52.6K	50,850
2021-07-26	Catalent, Inc.A Award	Group Pres. Pharma & Consumer	AAward	+885 sh	—	—	51,735
2021-07-26	Catalent, Inc.Options to purchase Common StockA Award	Group Pres. Pharma & Consumer	AAward	+4,579 sh	—	—	4,579
2021-01-04	Catalent, Inc.S Sale	Group Pres. Pharma & Consumer	SSale	−110 sh	$104.42	−$11.5K	51,315
2020-12-21	Catalent, Inc.M Exercise/Conversion	Group Pres. Pharma & Consumer	MExercise/Conversion	+3,936 sh	$24.44	+$96.2K	55,361
2020-12-21	Catalent, Inc.S Sale	Group Pres. Pharma & Consumer	SSale	−3,936 sh	$102.95	−$405K	51,425
2020-12-21	Catalent, Inc.M Exercise/Conversion	Group Pres. Pharma & Consumer	MExercise/Conversion	+9,726 sh	$36.02	+$350K	61,151
2020-12-21	Catalent, Inc.S Sale	Group Pres. Pharma & Consumer	SSale	−9,726 sh	$102.80	−$1M	51,425
2020-12-21	Catalent, Inc.Options to purchase Common StockM Exercise/Conversion	Group Pres. Pharma & Consumer	MExercise/Conversion	−3,936 sh	—	—	0
2020-12-21	Catalent, Inc.Options to purchase Common StockM Exercise/Conversion	Group Pres. Pharma & Consumer	MExercise/Conversion	−9,726 sh	—	—	3,243
2020-08-27	Catalent, Inc.A Award	Group Pres. Pharma & Consumer	AAward	+10.7K sh	—	—	55,409
2020-08-27	Catalent, Inc.F Tax Payment	Group Pres. Pharma & Consumer	FTax Payment	−4,226 sh	$87.71	−$371K	51,183
2020-08-27	Catalent, Inc.A Award	Group Pres. Pharma & Consumer	AAward	+400 sh	—	—	51,583
2020-08-27	Catalent, Inc.F Tax Payment	Group Pres. Pharma & Consumer	FTax Payment	−158 sh	$87.71	−$13.9K	51,425
2020-07-30	Catalent, Inc.A Award	Group Pres. Pharma & Consumer	AAward	+1,136 sh	—	—	44,672
2020-07-30	Catalent, Inc.Options to purchase Common StockA Award	Group Pres. Pharma & Consumer	AAward	+6,158 sh	—	—	6,158
2020-07-24	Catalent, Inc.F Tax Payment	Group Pres. Pharma & Consumer	FTax Payment	−984 sh	$81.64	−$80.3K	43,536
2020-06-25	Catalent, Inc.M Exercise/Conversion	Group Pres. Pharma & Consumer	MExercise/Conversion	+11.8K sh	$24.44	+$288K	56,319
2020-06-25	Catalent, Inc.F Tax Payment	Group Pres. Pharma & Consumer	FTax Payment	−7,039 sh	$73.00	−$514K	49,280
2020-06-25	Catalent, Inc.M Exercise/Conversion	Group Pres. Pharma & Consumer	MExercise/Conversion	+10.5K sh	$31.96	+$334K	59,736
2020-06-25	Catalent, Inc.F Tax Payment	Group Pres. Pharma & Consumer	FTax Payment	−6,891 sh	$73.00	−$503K	52,845
2020-06-25	Catalent, Inc.S Sale	Group Pres. Pharma & Consumer	SSale	−8,325 sh	$73.00	−$608K	44,520
2020-06-25	Catalent, Inc.Options to purchase Common StockM Exercise/Conversion	Group Pres. Pharma & Consumer	MExercise/Conversion	−11.8K sh	—	—	3,936
2020-06-25	Catalent, Inc.Options to purchase Common StockM Exercise/Conversion	Group Pres. Pharma & Consumer	MExercise/Conversion	−10.5K sh	—	—	0

Recent filings

Accepted (ET)
Dec 184
Gennadios Aristippos0000950170-24-137791
SEC(opens sec.gov)
Aug 54
Gennadios Aristippos0001596783-24-000066
SEC(opens sec.gov)
Jul 304
Gennadios Aristippos0001596783-24-000045
SEC(opens sec.gov)
Dec 124
Gennadios Aristippos0001596783-23-000219
SEC(opens sec.gov)
Dec 124/A
Gennadios Aristippos0001596783-23-000197
SEC(opens sec.gov)
Aug 254
Gennadios Aristippos0001596783-23-000098
SEC(opens sec.gov)
Aug 34
Gennadios Aristippos0001596783-23-000054
SEC(opens sec.gov)
Aug 264
Gennadios Aristippos0001596783-22-000115
SEC(opens sec.gov)
Jul 284
Gennadios Aristippos0001596783-22-000067
SEC(opens sec.gov)

Companies

Catalent, Inc.Group Pres. Pharma & Consumer

Address

14 SCHOOLHOUSE ROAD

SOMERSET, NJ, 08873